Fibrin sealant (Hemarus Therapeutics)

纤维蛋白胶(Hemarus Therapeutics)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFibrin sealant (Hemarus Therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionFibrin modulators
TargetsFibrinogen
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsWounds and Injuries
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2015/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHemarus Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHemarus Therapeutics
Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeB02BB01
Related LinksN/A